Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 139.58 USD 1.29%
Market Cap: 7B USD

Intrinsic Value

The intrinsic value of one AXSM stock under the Base Case scenario is 131.65 USD. Compared to the current market price of 139.58 USD, Axsome Therapeutics Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AXSM Intrinsic Value
131.65 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Axsome Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about AXSM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AXSM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Axsome Therapeutics Inc.

Explain Valuation
Compare AXSM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AXSM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Axsome Therapeutics Inc

Current Assets 565.3m
Cash & Short-Term Investments 325.3m
Receivables 196.5m
Other Current Assets 43.6m
Non-Current Assets 103.9m
PP&E 22.3m
Intangibles 54.2m
Other Non-Current Assets 27.5m
Efficiency

Free Cash Flow Analysis
Axsome Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Axsome Therapeutics Inc

Revenue
561.3m USD
Cost of Revenue
-45.7m USD
Gross Profit
515.6m USD
Operating Expenses
-730.3m USD
Operating Income
-214.7m USD
Other Expenses
-14.8m USD
Net Income
-229.5m USD
Fundamental Scores

AXSM Profitability Score
Profitability Due Diligence

Axsome Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
25/100
Profitability
Score

Axsome Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

AXSM Solvency Score
Solvency Due Diligence

Axsome Therapeutics Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
41/100
Solvency
Score

Axsome Therapeutics Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AXSM Price Targets Summary
Axsome Therapeutics Inc

Wall Street analysts forecast AXSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXSM is 180.65 USD with a low forecast of 149.48 USD and a high forecast of 210 USD.

Lowest
Price Target
149.48 USD
7% Upside
Average
Price Target
180.65 USD
29% Upside
Highest
Price Target
210 USD
50% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Axsome Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AXSM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AXSM Insider Trading
Buy and sell transactions by insiders

AXSM News

Other Videos
What is the Intrinsic Value of one AXSM stock?

The intrinsic value of one AXSM stock under the Base Case scenario is 131.65 USD.

Is AXSM stock undervalued or overvalued?

Compared to the current market price of 139.58 USD, Axsome Therapeutics Inc is Overvalued by 6%.

Back to Top